Customer Testimonial
John A. Burns
David Scicchitano Lab, New York University – Department of Biology
“Our lab routinely works with primary human fibroblasts which are notoriously difficult to transfect, and we require a method that is non-toxic, reliable, and reproducible. TransIT-2020 is the only reagent on the market that fits those criteria. In addition, TransIT-2020 also transfects colon cancer cell lines HCT-116 and DLD1 with much higher efficiencies. Overall, the pace and quality of our research have improved since we started using TransIT-2020.”
Data
Figure 1: TransIT-2020 Reagent Exhibits Higher Expression and Lower Cell Toxicity Compared to Other Transfection Reagents
Figure 2: High Performance Plasmid Transfection
Figure 3: Superior Gene Expression in a Broad Spectrum of Cell Types
Figure 4: TransIT®-2020 Reagent Effectively Transfects Drosophila S2 Cells